STOCK TITAN

Brookdale (BKD) director Denise Wilder granted 5,080 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Warren Denise Wilder reported acquisition or exercise transactions in this Form 4 filing.

Brookdale Senior Living Inc. director Denise Wilder received a grant of 5,080 shares of Common Stock on February 12, 2026. The shares were granted at $0 per share as unrestricted stock under the Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan.

After this award, Wilder directly beneficially owns 364,914 shares of Brookdale common stock, reflecting her equity stake as a board member and aligning her compensation partly with shareholders’ interests.

Positive

  • None.

Negative

  • None.

Insights

Director received stock grant as part of Brookdale’s 2024 incentive plan; routine alignment move.

Brookdale Senior Living Inc. granted director Denise Wilder 5,080 shares of common stock at $0 per share. The footnote explains this is an unrestricted stock grant under the 2024 Omnibus Incentive Plan, indicating standard board-level equity compensation.

Following the grant, Wilder directly holds 364,914 shares of common stock. This transaction is an acquisition via award rather than an open-market purchase or sale, so it does not inject or withdraw cash. It primarily updates disclosed insider ownership and continues equity-based alignment with shareholders.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Warren Denise Wilder

(Last) (First) (Middle)
C/O BROOKDALE SENIOR LIVING INC.
105 WESTWOOD PLACE, SUITE 400

(Street)
BRENTWOOD TN 37027

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Brookdale Senior Living Inc. [ BKD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/12/2026 A(1) 5,080 A $0 364,914 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of unrestricted shares of Common Stock under the Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan.
Remarks:
/s/ Chad C. White, By Power of Attorney 02/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Brookdale Senior Living Inc. (BKD) report for Denise Wilder?

Brookdale reported that director Denise Wilder received a grant of 5,080 shares of common stock on February 12, 2026. The shares were awarded at $0 per share as unrestricted stock, reflecting equity compensation rather than an open-market purchase.

How many Brookdale (BKD) shares does director Denise Wilder own after this grant?

After the award, director Denise Wilder beneficially owns 364,914 shares of Brookdale common stock. This figure comes directly from the ownership column, showing her updated direct stake following the 5,080-share grant reported in the insider filing.

Was the Brookdale (BKD) insider transaction a stock purchase or an equity grant?

The transaction was an equity grant, not a market purchase. The Form 4 shows transaction code A, described as a grant or award, and a footnote states it is a grant of unrestricted common shares under the 2024 Omnibus Incentive Plan.

What plan governed the 5,080-share award to Brookdale (BKD) director Denise Wilder?

The Brookdale Senior Living Inc. 2024 Omnibus Incentive Plan governed the grant. The footnote clarifies that the 5,080 unrestricted shares of common stock were issued pursuant to this plan, indicating standard incentive and retention compensation for company leadership.

Did Brookdale (BKD) receive cash from the 5,080-share grant to Denise Wilder?

No cash changed hands in this grant. The filing lists the transaction price as $0 per share, and describes it as a grant of unrestricted common stock, indicating it is non-cash equity compensation rather than a purchase that would provide cash proceeds to the company.

What does transaction code “A” mean in the Brookdale (BKD) insider filing for Denise Wilder?

Transaction code “A” in this context denotes a grant, award, or other acquisition of stock. The insider data labels the event as an acquisition, and the footnote specifies it is a grant of unrestricted common stock under Brookdale’s 2024 Omnibus Incentive Plan.
Brookdale Sr Living Inc

NYSE:BKD

View BKD Stock Overview

BKD Rankings

BKD Latest News

BKD Latest SEC Filings

BKD Stock Data

3.31B
230.54M
Medical Care Facilities
Services-nursing & Personal Care Facilities
Link
United States
BRENTWOOD